HOUSE 2732116th CongressReferred to the Subcommittee on Crime, Terrorism, and Homeland Security.

LABEL Opioids Act

Last Action: 6/26/2019

Actions

2019-06-26Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
2019-05-15Referred to the Subcommittee on Health.
2019-05-14Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-05-14Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-05-14Introduced in House
2019-05-14Introduced in House

CRS Summary

As of 2019-05-14 (00)

Lessening Addiction By Enhancing Labeling Opioids Act of 2019 or the LABEL Opioids Act

This bill requires prescription opioids to contain a warning label specifying that the opioids may cause dependence, addiction, and overdose.

Cosponsors (9)

Ben McAdams (D-UT)
Susan Wild (D-PA)
Jefferson Van Drew (D-NJ)
Mary Scanlon (D-PA)
Elaine Luria (D-VA)
BETTY MCCOLLUM (D-MN)
Jahana Hayes (D-CT)
BRAD SHERMAN (D-CA)
COLLIN PETERSON (D-MN)

Subjects

Administrative law and regulatory procedures
Consumer affairs
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Health information and medical records
Prescription drugs

Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.